Literature DB >> 29169938

Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection.

Page E Crew1, Nathaniel J Rhodes1, J Nicholas O'Donnell1, Cristina Miglis1, Elise M Gilbert2, Teresa R Zembower3, Chao Qi4, Christina Silkaitis5, Sarah H Sutton3, Marc H Scheetz6.   

Abstract

BACKGROUND: The purpose of this single-center, ecologic study is to characterize the relationship between facility-wide (FacWide) antibiotic consumption and incident health care facility-onset Clostridium difficile infection (HO-CDI).
METHODS: FacWide antibiotic consumption and incident HO-CDI were tallied on a monthly basis and standardized, from January 2013 through April 2015. Spearman rank-order correlation coefficients were calculated using matched-months analysis and a 1-month delay. Regression analyses were performed, with P < .05 considered statistically significant.
RESULTS: FacWide analysis identified a matched-months correlation between ceftriaxone and HO-CDI (ρ = 0.44, P = .018). A unit of stem cell transplant recipients did not have significant correlation between carbapenems and HO-CDI in matched months (ρ = 0.37, P = .098), but a significant correlation was observed when a 1-month lag was applied (ρ = 0.54, P = .014). DISCUSSION: Three statistically significant lag associations were observed between FacWide/unit-level antibiotic consumption and HO-CDI, and 1 statistically significant nonlagged association was observed FacWide. Antibiotic consumption may convey extended ward-level risk for incident CDI.
CONCLUSIONS: Consumption of antibiotic agents may have immediate and prolonged influence on incident CDI. Additional studies are needed to investigate the immediate and delayed associations between antibiotic consumption and C difficile colonization, infection, and transmission at the hospital level. Published by Elsevier Inc.

Entities:  

Keywords:  Antibiotic use; Antimicrobial stewardship; Healthcare-associated infections; Statistical model

Mesh:

Substances:

Year:  2017        PMID: 29169938     DOI: 10.1016/j.ajic.2017.09.015

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort.

Authors:  Martha L Carvour; Shane L Wilder; Keenan L Ryan; Carla Walraven; Fares Qeadan; Meghan Brett; Kimberly Page
Journal:  Am J Infect Control       Date:  2018-09-08       Impact factor: 2.918

Review 2.  Impact of antimicrobial therapy on the gut microbiome.

Authors:  Amira A Bhalodi; Tjitske S R van Engelen; Harjeet S Virk; W Joost Wiersinga
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

3.  Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.

Authors:  Mohammad Alrawashdeh; Chanu Rhee; Heather Hsu; Rui Wang; Kelly Horan; Grace M Lee
Journal:  JAMA Netw Open       Date:  2021-10-01

4.  Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.

Authors:  Ching-Chi Lee; Jen-Chieh Lee; Chun-Wei Chiu; Pei-Jane Tsai; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Microbiol Spectr       Date:  2021-10-20

5.  Correlation between antibiotic consumption and the incidence of healthcare facility-onset Clostridioides difficile infection: a retrospective chart review and analysis.

Authors:  Ji Hyun Yun; Ga Eun Park; Hyun Kyun Ki
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-06       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.